Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ranibizumab-eqrn
|
| gptkbp:approvalYear |
2022-08-02
|
| gptkbp:ATCCode |
S01LA04
|
| gptkbp:biosimilar |
gptkb:Lucentis
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
CIMERLI
|
| gptkbp:indication |
gptkb:diabetic_macular_edema
gptkb:neovascular_(wet)_age-related_macular_degeneration diabetic retinopathy macular edema following retinal vein occlusion |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Coherus_BioSciences
|
| gptkbp:powers |
6 mg/mL
|
| gptkbp:routeOfAdministration |
intravitreal injection
|
| gptkbp:bfsParent |
gptkb:Coherus_BioSciences
|
| gptkbp:bfsLayer |
7
|